High prevalence of escherichia coli sequence type 131 among antimicrobial-resistant E. Coli isolates from geriatric patients

Journal of Medical Microbiology

Volumn 64, Issue 3, 2015, Pages 243-247

  Ho, Pak Leung ^a   Chu, Yuki Pui Shan ^b   Lo, Wai U ^a   Chow, Kin Hung ^a   Law, Pierra Y ^a   Tse, Cindy Wing Sze ^c   Ng, Tak Keung ^d   Cheng, Vincent Chi Chung ^a   Que, Tak Lun ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b TUEN MUN HOSPITAL   (Hong Kong)

^c KWONG WAH HOSPITAL   (Hong Kong)

^d PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; ESCHERICHIA COLI PROTEIN; PRIMER DNA;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL LABORATORY; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GERIATRIC PATIENT; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; ADOLESCENT; ALLELE; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; GENETICS; GERIATRICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; SPECIES DIFFERENCE; URINARY TRACT; URINARY TRACT INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLELES; ANTI-INFECTIVE AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GERIATRICS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SPECIES SPECIFICITY; URINARY TRACT; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84923649687     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000012     Document Type: Article

References (32)

1. Arvand, M., Moser, V. & Pfeifer, Y. (2013). Prevalence of extended-spectrum-b-lactamase-producing Escherichia coli and spread of the epidemic clonal lineage ST131 in nursing homes in Hesse, Germany. J Antimicrob Chemother 68, 2686–2688.
2. Banerjee, R. & Johnson, J. R. (2014). A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother 58, 4997–5004.
3. Banerjee, R., Johnston, B., Lohse, C., Chattopadhyay, S., Tchesnokova, V., Sokurenko, E. V. & Johnson, J. R. (2013a). The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics. Antimicrob Agents Chemother 57, 5912–5917.
4. Banerjee, R., Robicsek, A., Kuskowski, M. A., Porter, S., Johnston, B. D., Sokurenko, E., Tchesnokova, V., Price, L. B. & Johnson, J. R. (2013b). Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago region, 2007 to 2010. Antimicrob Agents Chemother 57, 6385–6388.
5. Barber, A. E., Norton, J. P., Spivak, A. M. & Mulvey, M. A. (2013). Urinary tract infections: current and emerging management strat¬egies. Clin Infect Dis 57, 719–724.
6. Clermont, O., Johnson, J. R., Menard, M. & Denamur, E. (2007). Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis 57, 129–136.
7. Clermont, O., Dhanji, H., Upton, M., Gibreel, T., Fox, A., Boyd, D., Mulvey, M. R., Nordmann, P., Ruppé, E. & other authors (2009). Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 64, 274–277.
8. Clermont, O., Christenson, J. K., Denamur, E. & Gordon, D. M. (2013). The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep 5, 58–65.
9. CLSI (2014). Performance standards for antimicrobial susceptibility testing; 24th informational supplement M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute.
10. Colpan, A., Johnston, B., Porter, S., Clabots, C., Anway, R., Thao, L., Kuskowski, M. A., Tchesnokova, V., Sokurenko, E. V. & other authors (2013). Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis 57, 1256–1265.
11. Ho, P. L., Poon, W. W., Loke, S. L., Leung, M. S., Chow, K. H., Wong, R. C., Yip, K. S., Lai, E. L., Tsang, K. W. & COMBAT Study Group (2007a). Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother 60, 140–144.
12. Ho, P. L., Wong, R. C., Yip, K. S., Loke, S. L., Leung, M. S., Mak, G. C., Chow, F. K., Tsang, K. W., Que, T. L. & COMBAT Study Group (2007b). Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes. Diagn Microbiol Infect Dis 59, 439–445.
13. Ho, P. L., Yip, K. S., Chow, K. H., Lo, J. Y., Que, T. L. & Yuen, K. Y. (2010). Antimicrobial resistance among uropathogens that cause acute uncomplicated cystitis in women in Hong Kong: a prospective multicenter study in 2006 to 2008. Diagn Microbiol Infect Dis 66, 87–93.
14. Ho, P. L., Yeung, M. K., Lo, W. U., Tse, H., Li, Z., Lai, E. L., Chow, K. H., To, K. K. & Yam, W. C. (2012). Predominance of pHK01-like incompatibility group FII plasmids encoding CTX-M-14 among extended-spectrum beta-lactamase-producing Escherichia coli in Hong Kong, 1996–2008. Diagn Microbiol Infect Dis 73, 182–186.
15. Ho, P. L., Chau, P. H., Yan, M. K., Chow, K. H., Chen, J. H., Wong, S. C. & Cheng, V. C. (2014). High burden of extended-spectrum b-lactamase-positive Escherichia coli in geriatric patients. J Med Microbiol 63, 878–883.
16. Johnson, J. R., Menard, M., Johnston, B., Kuskowski, M. A., Nichol, K. & Zhanel, G. G. (2009). Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53, 2733–2739.
17. Johnson, J. R., Tchesnokova, V., Johnston, B., Clabots, C., Roberts, P. L., Billig, M., Riddell, K., Rogers, P., Qin, X. & other authors (2013). Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis 207, 919–928.
18. Johnson, J. R., Clermont, O., Johnston, B., Clabots, C., Tchesnokova, V., Sokurenko, E., Junka, A. F., Maczynska, B. & Denamur, E. (2014). Rapid and specific detection, molecular epidemiology, and experi¬mental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol 52, 1358–1365.
19. Kudinha, T., Johnson, J. R., Andrew, S. D., Kong, F., Anderson, P. & Gilbert, G. L. (2013). Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women. J Clin Microbiol 51, 3270–3276.
20. Lafolie, J., Nicolas-Chanoine, M. H., Grenouillet, F., Hocquet, D. & Bertrand, X. (2014). Prevalence of Escherichia coli sequence type 131 and its H30 subclone among E. coli isolates in a French hospital. Int J Antimicrob Agents 44, 466–468.
21. Leflon-Guibout, V., Blanco, J., Amaqdouf, K., Mora, A., Guize, L. & Nicolas-Chanoine, M. H. (2008). Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 46, 3900–3905.
22. Matsumura, Y., Yamamoto, M., Nagao, M., Hotta, G., Matsushima, A., Ito, Y., Takakura, S., Ichiyama, S. & Kyoto-Shiga Clinical Microbiology Study Group (2012). Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-b-lactamase-producing Escherichia coli in Japan. J Antimicrob Chemother 67, 2612–2620.
23. Naseer, U. & Sundsfjord, A. (2011). The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb Drug Resist 17, 83–97.
24. Nicolas-Chanoine, M. H., Bertrand, X. & Madec, J. Y. (2014). Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 27, 543–574.
25. Peirano, G. & Pitout, J. D. (2014). Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a Canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage. Antimicrob Agents Chemother 58, 2699–2703.
26. Peirano, G., van der Bij, A. K., Freeman, J. L., Poirel, L., Nordmann, P., Costello, M., Tchesnokova, V. L. & Pitout, J. D. (2014). Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum b-lactamases: global distribution of the H30-Rx sublineage. Antimicrob Agents Chemother 58, 3762–3767.
27. Petty, N. K., Ben Zakour, N. L., Stanton-Cook, M., Skippington, E., Totsika, M., Forde, B. M., Phan, M. D., Gomes Moriel, D., Peters, K. M. & other authors (2014). Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A 111, 5694–5699.
28. Price, L. B., Johnson, J. R., Aziz, M., Clabots, C., Johnston, B., Tchesnokova, V., Nordstrom, L., Billig, M., Chattopadhyay, S. & other authors (2013). The epidemic of extended-spectrum-b-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio 4, e00377–13.
29. Shin, J., Kim, J., Wie, S. H., Cho, Y. K., Lim, S. K., Shin, S. Y., Yeom, J. S., Lee, J. S., Kweon, K. T. & other authors (2012). Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact. Microb Drug Resist 18, 169–175.
30. Tchesnokova, V., Billig, M., Chattopadhyay, S., Linardopoulou, E., Aprikian, P., Roberts, P. L., Skrivankova, V., Johnston, B., Gileva, A. & other authors (2013). Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome. J Clin Microbiol 51, 2991–2999.
31. Weissman, S. J., Johnson, J. R., Tchesnokova, V., Billig, M., Dykhuizen, D., Riddell, K., Rogers, P., Qin, X., Butler-Wu, S. & other authors (2012). High-resolution two-locus clonal typing of extra-intestinal pathogenic Escherichia coli. Appl Environ Microbiol 78, 1353–1360.
32. Wirth, T., Falush, D., Lan, R., Colles, F., Mensa, P., Wieler, L. H., Karch, H., Reeves, P. R., Maiden, M. C. & other authors (2006). Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60, 1136–1151.